DocMorris AG

SWX:DOCM Stock Report

Market Cap: CHF 268.0m

DocMorris Future Growth

Future criteria checks 1/6

DocMorris is forecast to grow earnings and revenue by 41.7% and 13% per annum respectively. EPS is expected to grow by 72.6% per annum. Return on equity is forecast to be -8.9% in 3 years.

Key information

41.7%

Earnings growth rate

72.55%

EPS growth rate

Consumer Retailing earnings growth13.6%
Revenue growth rate13.0%
Future return on equity-8.86%
Analyst coverage

Good

Last updated18 Dec 2025

Recent future growth updates

Recent updates

Is DocMorris (VTX:DOCM) Using Too Much Debt?

Oct 23
Is DocMorris (VTX:DOCM) Using Too Much Debt?

A Piece Of The Puzzle Missing From DocMorris AG's (VTX:DOCM) 28% Share Price Climb

Aug 06
A Piece Of The Puzzle Missing From DocMorris AG's (VTX:DOCM) 28% Share Price Climb

Positive Sentiment Still Eludes DocMorris AG (VTX:DOCM) Following 33% Share Price Slump

Jun 15
Positive Sentiment Still Eludes DocMorris AG (VTX:DOCM) Following 33% Share Price Slump

DocMorris AG (VTX:DOCM) Stock Rockets 35% But Many Are Still Ignoring The Company

May 01
DocMorris AG (VTX:DOCM) Stock Rockets 35% But Many Are Still Ignoring The Company

Does DocMorris (VTX:DOCM) Have A Healthy Balance Sheet?

Apr 11
Does DocMorris (VTX:DOCM) Have A Healthy Balance Sheet?

The DocMorris AG (VTX:DOCM) Yearly Results Are Out And Analysts Have Published New Forecasts

Mar 16
The DocMorris AG (VTX:DOCM) Yearly Results Are Out And Analysts Have Published New Forecasts

Sentiment Still Eluding DocMorris AG (VTX:DOCM)

Mar 14
Sentiment Still Eluding DocMorris AG (VTX:DOCM)

It's Down 30% But DocMorris AG (VTX:DOCM) Could Be Riskier Than It Looks

Dec 10
It's Down 30% But DocMorris AG (VTX:DOCM) Could Be Riskier Than It Looks

DocMorris AG's (VTX:DOCM) Subdued P/S Might Signal An Opportunity

Oct 25
DocMorris AG's (VTX:DOCM) Subdued P/S Might Signal An Opportunity

Does DocMorris (VTX:DOCM) Have A Healthy Balance Sheet?

Sep 22
Does DocMorris (VTX:DOCM) Have A Healthy Balance Sheet?

Would Zur Rose Group (VTX:ROSE) Be Better Off With Less Debt?

Sep 07
Would Zur Rose Group (VTX:ROSE) Be Better Off With Less Debt?

We Think Zur Rose Group (VTX:ROSE) Has A Fair Chunk Of Debt

Dec 05
We Think Zur Rose Group (VTX:ROSE) Has A Fair Chunk Of Debt

We Think Zur Rose Group (VTX:ROSE) Has A Fair Chunk Of Debt

Aug 22
We Think Zur Rose Group (VTX:ROSE) Has A Fair Chunk Of Debt

Earnings and Revenue Growth Forecasts

SWX:DOCM - Analysts future estimates and past financials data (CHF Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/20271,502-45-2428
12/31/20261,302-80-61-258
12/31/20251,119-107-97-618
6/30/20251,062-121-99-71N/A
3/31/20251,052-114-93-64N/A
12/31/20241,017-97-55-27N/A
9/30/20241,010-97-75-45N/A
6/30/20241,003-97-95-63N/A
3/31/2024984-97-88-57N/A
12/31/2023969-118-119-87N/A
9/30/2023934-132-124-90N/A
6/30/2023899-146-129-93N/A
3/31/2023915-158-136-95N/A
12/31/2022931-171-144-97N/A
9/30/20221,156-202-178-126N/A
6/30/20221,381-232-212-155N/A
3/31/20221,554-229-203-143N/A
12/31/20211,727-226-194-131N/A
9/30/20211,673-193-155-87N/A
6/30/20211,619-160-116-43N/A
3/31/20211,548-148-122-55N/A
12/31/20201,477-136-127-68N/A
9/30/20201,431-112-138-88N/A
6/30/20201,385-88-149-108N/A
3/31/20201,370-70-137-95N/A
12/31/20191,356-52-124-83N/A
9/30/20191,314-45N/AN/AN/A
6/30/20191,272-39-67-35N/A
3/31/20191,240-39N/A-34N/A
12/31/20181,207-39N/A-33N/A
9/30/20181,166-37N/AN/AN/A
6/30/20181,125-36N/A-30N/A
3/31/20181,061-36N/AN/AN/A
12/31/2017990-36N/A-22N/A
9/30/2017953-34N/A-21N/A
6/30/2017915-31N/A-21N/A
3/31/2017900-21N/AN/AN/A
12/31/2016884-13N/A-14N/A
9/30/2016873-4N/AN/AN/A
6/30/20168616N/AN/AN/A
3/31/20168474N/AN/AN/A
12/31/20158383N/A19N/A
9/30/20158574N/AN/AN/A
6/30/20158755N/AN/AN/A
3/31/20158986N/AN/AN/A
12/31/20149207N/A7N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: DOCM is forecast to remain unprofitable over the next 3 years.

Earnings vs Market: DOCM is forecast to remain unprofitable over the next 3 years.

High Growth Earnings: DOCM is forecast to remain unprofitable over the next 3 years.

Revenue vs Market: DOCM's revenue (13% per year) is forecast to grow faster than the Swiss market (3.9% per year).

High Growth Revenue: DOCM's revenue (13% per year) is forecast to grow slower than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: DOCM is forecast to be unprofitable in 3 years.

Discover growth companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/12/21 21:44
End of Day Share Price 2025/12/19 00:00
Earnings2025/06/30
Annual Earnings2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

DocMorris AG is covered by 18 analysts. 8 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Volker BosseBaader Helvea Equity Research
Sarah RobertsBarclays
Gerhard OrgonasBerenberg